You are here

Article Text

Article menu
Download PDFPDF
Lesson of the month
Cerebral infarction complicating intravenous immunoglobulin therapy in a patient with Miller Fisher syndrome
  1. Benjamin Turner,
  2. Adrian J Wills
  1. Division of Clinical Neurology, University Hospital, Queen's Medical Centre, Nottingham NG7 2UH, UK
  1. Dr B Turnernnxbt{at}nnn1.nottingham.ac.uk

Abstract

Intravenous immunoglobulin (IVIg) therapy is being increasingly used in a wide range of neurological conditions. However, treatment is expensive and side effects may be severe. A patient with Miller Fisher syndrome who developed cortical blindness as a consequence of occipital infarction precipitated by IVIg is reported on.

  • Miller Fisher syndrome
  • intravenous immunoglobulin
  • cerebral infarction

https://doi.org/10.1136/jnnp.68.6.790

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes